Your browser doesn't support javascript.
loading
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
Walker, Alison R; Marcucci, Guido; Yin, Jun; Blum, William; Stock, Wendy; Kohlschmidt, Jessica; Mrózek, Krzysztof; Carroll, Andrew J; Eisfeld, Ann-Kathrin; Wang, Eunice S; Jacobson, Sawyer; Kolitz, Jonathan E; Thakuri, Mohan; Sutamtewagul, Grerk; Vij, Ravi; Stuart, Robert K; Byrd, John C; Bloomfield, Clara D; Stone, Richard M; Larson, Richard A.
Afiliación
  • Walker AR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Marcucci G; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Yin J; Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Blum W; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Stock W; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
  • Kohlschmidt J; University of Chicago Comprehensive Cancer Center, Chicago, IL.
  • Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Carroll AJ; Alliance Statistics and Data Center, The Ohio State University, Columbus, OH.
  • Eisfeld AK; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Wang ES; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL.
  • Jacobson S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Kolitz JE; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Thakuri M; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Sutamtewagul G; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Vij R; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY.
  • Stuart RK; Southeast Clinical Oncology Research Consortium, National Cancer Institute Community Oncology Research Program, Cancer Care of Western North Carolina, Asheville, NC.
  • Byrd JC; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA.
  • Bloomfield CD; Division of Hematology and Oncology, Washington University School of Medicine, St Louis, MO.
  • Stone RM; Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; and.
  • Larson RA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
Blood Adv ; 5(13): 2775-2787, 2021 07 13.
Article en En | MEDLINE | ID: mdl-34251414
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article